The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
You don't have to be rich to run with Jim Cramer. You can generate big profits even if you have a small wallet.
Although the "Mad Money" host doesn't think that 'buy' decisions should ever be based on a stock's price, per share, he does recognize that not everyone has the capital to buy high dollar stocks.
Therefore, he's been scouring the market looking for a good stock that doesn't cost a lot. And his research has led him to Rite Aid which closed Friday slightly under $7.
In fact, of all the stocks trading below $10, Cramer likes Rite Aid best. He believes the company and therefore shares are facing a slew of tailwinds. For example:
1. Regardless of how you feel about the there's no doubt at this point that it's going to allow millions of uninsured people to get healthcare coverage, and the more people who have insurance, the more prescriptions Rite-Aid can fill.
2. The , every year our country's demographics skew older and older, and older people need more prescriptions.
3. This year alone will total $35 billion. That's bullish for the bottom line because generic drugs carry much higher margins for pharmacies than patent protected ones.
Of course, Cramer realizes that the catalysts outline above should benefit all drug stores, not just Rite Aid. However, there are additional catalysts that he sees that are specific to this company.
A. Rite-Aid has implemented an aggressive remodeling program. In the last three years, Rite-Aid has converted 1,200 of its 4,600 stores, more than a quarter, to their new format. "The new format delivers front-end same store sales that are 300 basis points higher than the non-remodeled locations," Cramer said.
B. Rite-Aid has aggressively shut down underperforming stores to focus on profitability.
C. Rite Aid has 25 million loyalty card members, and over the past year, Rite-Aid has been using information collected from those costumers to bring a new level of sophistication to their targeted marketing campaigns. "Ultimately, that creates more traffic and customers buying more merchandise on each visit," Cramer said.
Read more from Mad Money with Jim Cramer
Cramer goes behind the selling
Stock pick between $10-$50
Dimon does bull a solid
When you add up items 1,2 and 3 and combine them with A,B and C, Cramer says you get plenty of positive catalysts. "Therefore, I think there's a lot more upside ahead, however, there's a small caveat.
"I also don't want you to chase," Cramer said. Shares popped more than 12% over the last 5 days, due to the Street's enthusiasm about earnings. "Although I like the stock I wouldn't buy right away. I'd wait and buy into weakness. And considering the volatility of this market, I think you'll get a lower entry point before you know it."
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the "Mad Money" website? email@example.com